![Ed Feener](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Edward P.
Feener is the founder of KalVista Pharmaceuticals Ltd., founded in 2011, serving as Chief Scientific Officer since 2011.
Dr. Feener is the founder of KalVista Pharmaceuticals, Inc., founded in 2004, serving as Chief Scientific Officer since 2016.
Dr. Feener was Associate Professor at Harvard Medical School from 1989 to 2016.
Dr. Feener earned a doctorate from Boston University in 1989.
Postes actifs de Ed Feener
| Sociétés | Poste | Début |
|---|---|---|
| KALVISTA PHARMA | Fondateur | 26/03/2004 |
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral medicines | Fondateur | 01/01/2011 |
Anciens postes connus de Ed Feener
| Sociétés | Poste | Fin |
|---|---|---|
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/10/2016 |
Formation de Ed Feener
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KalVista Pharmaceuticals Ltd.
KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral medicines | Health Technology |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
